Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination regimen improves overall survival in certain patients with AML

A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.

12 Aug 2020

Bayer supports WHO through donated medicines for treatment of T. solium infection

A recent agreement between the World Health Organization and the German pharmaceutical company Bayer promises hope of expanding access to essential medicines for the treatment of people exposed to or infected by the pork tapeworm Taenia solium.

12 Aug 2020

Acupuncture can tame cytokine storm in mice with systemic inflammation

A team of researchers led by neuroscientists at Harvard Medical School has successfully used acupuncture to tame cytokine storm in mice with systemic inflammation.

12 Aug 2020

COMBAT study shows how pancreatic cancer patients can benefit from immunotherapy

Working with an international team of researchers, HonorHealth Research Institute and the Translational Genomics Research Institute, an affiliate of City of Hope, were instrumental in one of the first clinical trials showing how pancreatic cancer patients can benefit from immunotherapy, according to a four-year study published in a premier scientific journal, Nature Medicine.

11 Aug 2020

Updated clinical practice guidelines for managing mucositis published

Updated clinical practice guidelines for managing mucositis, a very common and often debilitating complication of cancer therapy, was recently published in the journal Cancer.

11 Aug 2020

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer patients who currently have very few treatment options.

11 Aug 2020

Researchers discover dose threshold that improves delivery of cancer-fighting drugs into a tumor

University of Toronto Engineering researchers have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumor.

11 Aug 2020

NIH supports research on how pathogens evolve

For several years, physicist John Barton at the University of California, Riverside, has been working on developing models to understand and predict how pathogens, such as HIV, evolve. This research pursuit has just received support from the National Institutes of Health.

10 Aug 2020

UT Southwestern physicians eliminate sociodemographic disparities in testicular cancer patients

By offering the same level of care and expertise to two very different populations, UT Southwestern physicians were able to eliminate the sociodemographic disparities in survival and cancer recurrence rates typically seen nationally in testicular cancer patients.

10 Aug 2020

Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM

A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.

7 Aug 2020

Researchers use patient-specific tumor organoid to optimize chemotherapy for appendix, colon tumors

A patient-specific tumor organoid model is being used to identify the most effective chemotherapy protocol to treat appendix and colon tumors, a personalized medicine approach that is showing promise.

7 Aug 2020

Chemotherapy not commonly used when treating adults with localized sarcoma

UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.

6 Aug 2020

Chemists discover a way to create synthetic version of natural anti-cancer compound

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

6 Aug 2020

ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia

Today, ASH published new guidelines to help older adults with acute myeloid leukemia (AML) and their health care providers make critical care decisions, including if and how to proceed with cancer treatment and the need for blood transfusions for those in hospice care.

6 Aug 2020

Gene could predict treatment response in certain breast cancer patients

Scientists have identified a gene which if present in certain breast cancer patients indicates how they will respond to specific therapies.

6 Aug 2020

3D organoid model helps better understand how tumor grows in natural microenvironment

Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have biofabricated human colorectal cancer miniature organs, called organoids, to better understand how a tumor grows in its natural microenvironment and its response to therapies.

5 Aug 2020

Study: Inhibition of TLK protein stimulates the innate immune system

Tousled-like kinases (TLKs) are a potential therapeutic target for cancer treatment due to their central role in DNA repair and replication.

5 Aug 2020

Panthera’s oncology clinical trial sites in the UK are open for research activities

Over a thousand oncology clinical trials have been suspended due to Covid putting back research which is vital for patients across the world.

5 Aug 2020

Novel technology tests the presence of thin membrane protrusions on breast cancer cells

Researchers at the University of Maryland School of Medicine (UMSOM) have developed a novel technology to test for the presence of thin membrane protrusions called "microtentacles" on breast cancer cells, which can help predict whether a tumor is likely to spread.

5 Aug 2020

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

A team led by Massimo Squatrito, Head of the Seve Ballesteros Foundation Brain Tumour Group at the Spanish National Cancer Research Centre, have made important findings of how some gliomas can acquire chemoresistance.

4 Aug 2020

Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination regimen improves overall survival in certain patients with AML

Bayer supports WHO through donated medicines for treatment of T. solium infection

Acupuncture can tame cytokine storm in mice with systemic inflammation

COMBAT study shows how pancreatic cancer patients can benefit from immunotherapy

Updated clinical practice guidelines for managing mucositis published

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

Researchers discover dose threshold that improves delivery of cancer-fighting drugs into a tumor

NIH supports research on how pathogens evolve

UT Southwestern physicians eliminate sociodemographic disparities in testicular cancer patients

Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM

Researchers use patient-specific tumor organoid to optimize chemotherapy for appendix, colon tumors

Chemotherapy not commonly used when treating adults with localized sarcoma

Chemists discover a way to create synthetic version of natural anti-cancer compound

ASH publishes new guidelines to help tailor treatment for older adults with acute myeloid leukemia

Gene could predict treatment response in certain breast cancer patients

3D organoid model helps better understand how tumor grows in natural microenvironment

Study: Inhibition of TLK protein stimulates the innate immune system

Panthera’s oncology clinical trial sites in the UK are open for research activities

Novel technology tests the presence of thin membrane protrusions on breast cancer cells

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in